+ Follow DR. DONALD TASHKIN Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 129997
[Title] => Anti-smoking drug for COPD sufferers
[Summary] => Smokers with Chronic Obstructive Pulmonary Disease (COPD), a smoking-related illness that is one of the leading causes of morbidity and mortality worldwide, may be able to quit smoking successfully with the use of a drug containing bupropion hydrochloride.
According to the results of a study published in the latest issue of the medical journal Lancet, bupropion hydrochloride SR is an effective and well-tolerated aid to smoking cessation in smokers with mild to moderate COPD.
Approximately 80 to 90 percent of all COPD cases are associated with smoking.
[DatePublished] => 2001-08-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
DR. DONALD TASHKIN
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 129997
[Title] => Anti-smoking drug for COPD sufferers
[Summary] => Smokers with Chronic Obstructive Pulmonary Disease (COPD), a smoking-related illness that is one of the leading causes of morbidity and mortality worldwide, may be able to quit smoking successfully with the use of a drug containing bupropion hydrochloride.
According to the results of a study published in the latest issue of the medical journal Lancet, bupropion hydrochloride SR is an effective and well-tolerated aid to smoking cessation in smokers with mild to moderate COPD.
Approximately 80 to 90 percent of all COPD cases are associated with smoking.
[DatePublished] => 2001-08-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
August 13, 2001 - 12:00am